Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupa Banerjee

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
The Lancet. Gastroenterology & Hepatology|November 12, 2020
Optimising management strategies of inflammatory bowel disease in resource-limited settings in AsiaSiew C Ng, Joyce Wing Yan Mak, Partha Pal, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|December 30, 2008
Application of high-resolution narrow band imaging and endocytoscopy for early diagnosis of esophageal neoplasiaRupa Banerjee, D Nageshwar Reddy, G Venkat Rao, et al.
Intestinal Research|August 3, 2019
Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behaviorRupa Banerjee, Partha Pal, Susan Hutfless, et al.
The FEBS Journal|June 2, 2016
Monitoring conformational heterogeneity of the lid of DnaK substrate-binding domain during its chaperone cycleRupa Banerjee, Gopal Gunanathan Jayaraj, Joshua Jebakumar Peter, et al.
Intestinal Research|November 19, 2020
Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset diseaseRupa Banerjee, Partha Pal, Zaheer Nabi, et al.
BMC Gastroenterology|October 15, 2016
Addition of Lubiprostone to polyethylene glycol(PEG) enhances the quality & efficacy of colonoscopy preparation: a randomized, double-blind, placebo controlled trialRupa Banerjee, Hrushikesh Chaudhari, Nirish Shah, et al.
Digestive Diseases and Sciences|April 30, 2013
Granulomas of intestinal tuberculosis and Crohn's disease can be differentiated by CD73 cell surface marker expression: a pilot studyRupa Banerjee, M Balaji, M Sasikala, et al.
The Journal of the Association of Physicians of India|September 6, 2011
CYP2C19 polymorphism as a predictor of personalized therapy in South Indian populationSiva Prasad Siddapuram, Rupa Banerjee, Manu Tandan, et al.
World Journal of Gastroenterology|September 29, 2006
Efficacy of low dose peginterferon alpha-2b with ribavirin on chronic hepatitis CRajesh Gupta, C H Ramakrishna, Sandeep Lakhtakia, et al.
Journal of Clinical Gastroenterology|September 5, 2020
Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot StudyRupa Banerjee, Partha Pal, Amulya Penmetsa, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
The Lancet. Gastroenterology & Hepatology|November 12, 2020
Optimising management strategies of inflammatory bowel disease in resource-limited settings in AsiaSiew C Ng, Joyce Wing Yan Mak, Partha Pal, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|December 30, 2008
Application of high-resolution narrow band imaging and endocytoscopy for early diagnosis of esophageal neoplasiaRupa Banerjee, D Nageshwar Reddy, G Venkat Rao, et al.
Intestinal Research|August 3, 2019
Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behaviorRupa Banerjee, Partha Pal, Susan Hutfless, et al.
The FEBS Journal|June 2, 2016
Monitoring conformational heterogeneity of the lid of DnaK substrate-binding domain during its chaperone cycleRupa Banerjee, Gopal Gunanathan Jayaraj, Joshua Jebakumar Peter, et al.
Intestinal Research|November 19, 2020
Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset diseaseRupa Banerjee, Partha Pal, Zaheer Nabi, et al.
BMC Gastroenterology|October 15, 2016
Addition of Lubiprostone to polyethylene glycol(PEG) enhances the quality & efficacy of colonoscopy preparation: a randomized, double-blind, placebo controlled trialRupa Banerjee, Hrushikesh Chaudhari, Nirish Shah, et al.
Digestive Diseases and Sciences|April 30, 2013
Granulomas of intestinal tuberculosis and Crohn's disease can be differentiated by CD73 cell surface marker expression: a pilot studyRupa Banerjee, M Balaji, M Sasikala, et al.
The Journal of the Association of Physicians of India|September 6, 2011
CYP2C19 polymorphism as a predictor of personalized therapy in South Indian populationSiva Prasad Siddapuram, Rupa Banerjee, Manu Tandan, et al.
World Journal of Gastroenterology|September 29, 2006
Efficacy of low dose peginterferon alpha-2b with ribavirin on chronic hepatitis CRajesh Gupta, C H Ramakrishna, Sandeep Lakhtakia, et al.
Journal of Clinical Gastroenterology|September 5, 2020
Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot StudyRupa Banerjee, Partha Pal, Amulya Penmetsa, et al.
Pageof 10